DNAGinkgo+PlatformTWSTTwist+SynthesisABSIAbsci+AIDesignCRSPCRISPR Therapeutics+EditBEAMBeam+BaseEditNTLAIntellia+InVivoCRBUCaribou+CellTherapyRXRXRecursion+AIILMNIllumina+SeqEDITEditas+GeneFUND.YTD2025$17.3B.Raised
activeFounded 2016

bit.bio

HQ: Cambridge, UKCEO: Mark KotterHeadcount: 150+bit.bio
Funding Summary
Total Funding
$200M+
Latest Valuation
Undisclosed
About

Uses combinatorial gene expression to precisely reprogram human iPSCs into any cell type on demand via opti-ox technology.

platform Programs
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →